Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.3.1.900
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jan. 02, 2016
Jan. 03, 2015
Dec. 28, 2013
Operating activities      
Net loss including noncontrolling interests $ (2,424) $ (7,086) $ (15,634)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:      
Depreciation and amortization expense 7,510 8,923 12,175
Amortization of intangible assets 464 422 381
Deferred income taxes (906) 74 59
Share-based compensation expense 2,419 2,371 1,263
Stock awards issued for non-employee director service 2 0 31
Impairment loss on property and equipment 0 0 4,832
Impairment loss on intangible assets 0 0 1,245
Amortization of deferred financing costs 82 81 81
Loss (gain) from disposition of assets (13) (96) (35)
Changes in operating assets and liabilities:      
Accounts receivable 568 1,105 2,403
Inventory (2,854) (11,412) 5,740
Other current assets 262 471 954
Other non-current assets 225 (39) (213)
Accounts payable and accrued expenses 119 6,992 (11,833)
Other current liabilities 475 (302) (1,054)
Other non-current liabilities (184) (261) 472
Net cash provided by (used in) operating activities 5,745 1,243 867
Investing activities      
Additions to property and equipment (7,780) (5,556) (8,325)
Proceeds from sale of property and equipment 13 27 47
Cash paid for intangibles (25) (200) 0
Proceeds from sale of marketable securities and investments 0 745 52
Purchases of marketable securities and investments 0 (746) (7)
Purchases of company-owned life insurance 0 0 (106)
Net cash used in investing activities (7,792) (5,730) (8,339)
Financing activities      
Proceeds from revolving loan payable 15,637 19,506 19,561
Payments made on revolving loan payable (14,900) (15,258) (29,008)
Proceeds from sale-leaseback transaction 0 0 9,584
Proceeds from issuance of Series A convertible preferred stock 0 0 6,017
Payment of issuance costs from Series A convertible preferred stock 0 0 (847)
Proceeds from issuance of common stock 0 0 2,235
Payment of issuance costs from common stock 0 0 (244)
Proceeds from sale of equity in subsidiary 0 7,000 0
Payments on capital leases (438) (232) (198)
Statutory tax witholding payment for share-based compensation (438) 0 0
Proceeds from exercise of stock options 134 295 183
Payment of liabilities related to financing activities (100) 0 (64)
Net cash provided by (used in) financing activities (105) 11,311 7,219
Effect of exchange rate changes on cash 36 11 41
Net change in cash and cash equivalents (2,116) 6,835 (212)
Cash and cash equivalents, beginning of period 7,653 818 1,030
Cash and cash equivalents, end of period 5,537 7,653 818
Supplemental disclosure of non-cash investing and financing activities:      
Accrued asset purchases 708 1,232 736
Accrued intangible asset purchases 125 0 0
Property acquired under capital lease 1,588 0 322
Unrealized gain on investments 0 0 7
Supplemental disclosure of cash flow information:      
Cash paid during the period for income taxes 104 60 43
Cash paid during the period for interest $ 1,145 $ 1,029 $ 884